Summary:
- The article discusses the potential negative impact of activist investors on healthcare innovation and the development of new treatments and technologies.
- It argues that activist investors often prioritize short-term financial gains over long-term research and development, which can stifle the ability of healthcare companies to invest in and bring new innovations to market.
- The article suggests that policymakers should consider ways to protect healthcare companies from excessive pressure from activist investors, in order to encourage a more conducive environment for medical and technological advancements.